Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12000 participants
OBSERVATIONAL
2002-01-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
But the relationship between transfusion and inflammatory condition are bidirectional. The patient's inflammatory condition will sound on the effectiveness of transfusion and transfusion could trigger an inflammatory condition. This has been reported with the said blood components "aged", especially with packed red cells in patients hospitalized in intensive care after heavy heart surgery.The main objective of this study is to evaluate the impact of early transfusions on the evolution of renal transplantation (ie death, anti-HLA immunization, acute rejection, graft loss, delayed graft function, cardiovascular events ) taking into account in the analysis: patient age at the time of transplantation, the number of incompatibility (s) (HLA class I and / or II) between the graft and the patient and sex of the recipient.
This is a multicenter retrospective observational study (descriptive epidemiological study).The impact of early transfusions is determined retrospectively over a period of 6 years from 01 January 2002 to 31 December 2008, in renal transplant patients of all centers of France met the criteria for inclusion. This cohort represents about 12 000-14 000 patients
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Orientation of the Lymphocyte Response to the Occurrence of Atherosclerotic Complications After Kidney Transplantation
NCT02843867
Impact of the Composition of Packed Red Blood Cell Supernatant on Renal Dysfunction and Posttransfusion Immunomodulation
NCT02763410
Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange
NCT03436134
The Study of Long-term Deterioration of Kidney Transplants.
NCT00217126
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
NCT06025240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who received a first kidney transplant
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agence de La Biomédecine
OTHER_GOV
Etablissement Français du Sang
OTHER
Amiens University Hospital
OTHER
University Hospital, Angers
OTHER_GOV
Bicetre Hospital
OTHER
University Hospital, Bordeaux
OTHER
University Hospital, Brest
OTHER
University Hospital, Caen
OTHER
University Hospital, Clermont-Ferrand
OTHER
CRC CHI Creteil France
OTHER_GOV
Centre Hospitalier Universitaire Dijon
OTHER
Hopital Foch
OTHER
University Hospital, Grenoble
OTHER
Groupe Hospitalier Pitie-Salpetriere
OTHER
University Hospital, Lille
OTHER
University Hospital, Limoges
OTHER
Hôpital Edouard Herriot
OTHER
Centre Hospitalier Lyon Sud
OTHER
University Hospital, Marseille
OTHER
University Hospital, Montpellier
OTHER
Central Hospital, Nancy, France
OTHER
Nantes University Hospital
OTHER
Hôpital Necker-Enfants Malades
OTHER
Centre Hospitalier Universitaire de Nice
OTHER
Poitiers University Hospital
OTHER
CHU de Reims
OTHER
Rennes University Hospital
OTHER
CHU de Rouen - Accueil
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Saint-Louis Hospital, Paris, France
OTHER
University Hospital, Strasbourg, France
OTHER
Tenon Hospital, Paris
OTHER
University Hospital, Toulouse
OTHER
University Hospital, Tours
OTHER
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/2013/166
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.